These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21206864)

  • 21. Fixed-dose combination tablet of repaglinide and metformin is bioequivalent to concomitantly administered individual tablets of repaglinide and metformin : randomized, single-blind, three-period crossover study in healthy subjects.
    Hoelscher D; Chu PL; Lyness W
    Clin Drug Investig; 2008; 28(9):573-82. PubMed ID: 18666804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
    Davidson MH; Rooney MW; Drucker J; Eugene Griffin H; Oosman S; Beckert M;
    Clin Ther; 2009 Dec; 31(12):2824-38. PubMed ID: 20110022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Olanzapine augmentation of milnacipran for stage 2 treatment-resistant major depression: an open study.
    Boku S; Inoue T; Honma H; Honma H; Nakagawa S; Koyama T
    Hum Psychopharmacol; 2011 Apr; 26(3):237-41. PubMed ID: 21638328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective Study of Olanzapine in Depressive and Anxious States in Primary Care.
    Jackson WC; Manning JS; Connor PD; Deardorff OG
    Prim Care Companion J Clin Psychiatry; 2004; 6(5):199-202. PubMed ID: 15514689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder.
    Taneja C; Papakostas GI; Jing Y; Baker RA; Forbes RA; Oster G
    Ann Pharmacother; 2012 May; 46(5):642-9. PubMed ID: 22550279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of Bright Light Treatment, Fluoxetine, and the Combination in Patients With Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial.
    Lam RW; Levitt AJ; Levitan RD; Michalak EE; Cheung AH; Morehouse R; Ramasubbu R; Yatham LN; Tam EM
    JAMA Psychiatry; 2016 Jan; 73(1):56-63. PubMed ID: 26580307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
    Perry MS
    Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of life in children and adolescents with bipolar I depression treated with olanzapine/fluoxetine combination.
    Walker DJ; DelBello MP; Landry J; D'Souza DN; Detke HC
    Child Adolesc Psychiatry Ment Health; 2017; 11():34. PubMed ID: 28706563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depression.
    Perlis RH; Adams DH; Fijal B; Sutton VK; Farmen M; Breier A; Houston JP
    J Clin Psychiatry; 2010 May; 71(5):599-605. PubMed ID: 20021991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Black hairy tongue with a fixed dose combination of olanzapine and fluoxetine.
    Jhaj R; Gour PR; Asati DP
    Indian J Pharmacol; 2016; 48(3):318-20. PubMed ID: 27298505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial.
    Strik JJ; Honig A; Lousberg R; Lousberg AH; Cheriex EC; Tuynman-Qua HG; Kuijpers PM; Wellens HJ; Van Praag HM
    Psychosom Med; 2000; 62(6):783-9. PubMed ID: 11138997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.
    Levitan RD; Shen JH; Jindal R; Driver HS; Kennedy SH; Shapiro CM
    J Psychiatry Neurosci; 2000 Sep; 25(4):337-46. PubMed ID: 11022398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term safety and efficacy of single-tablet combinations of solifenacin and tamsulosin oral controlled absorption system in men with storage and voiding lower urinary tract symptoms: results from the NEPTUNE Study and NEPTUNE II open-label extension.
    Drake MJ; Chapple C; Sokol R; Oelke M; Traudtner K; Klaver M; Drogendijk T; Van Kerrebroeck P;
    Eur Urol; 2015 Feb; 67(2):262-70. PubMed ID: 25070148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Moclobemide versus fluoxetine for double depression: a randomized double-blind study.
    Duarte A; Mikkelsen H; Delini-Stula A
    J Psychiatr Res; 1996; 30(6):453-8. PubMed ID: 9023788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of olanzapine-fluoxetine combination treatment of major depressive disorders on the quality of life during acute treatment period.
    Qu W; Gu S; Luo H; Tang Q; Guo J
    Cell Biochem Biophys; 2014 Dec; 70(3):1799-802. PubMed ID: 25062968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain region and dose effects of an olanzapine/fluoxetine combination on extracellular monoamine concentrations in the rat.
    Koch S; Perry KW; Bymaster FP
    Neuropharmacology; 2004 Feb; 46(2):232-42. PubMed ID: 14680761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
    Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S
    J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.